Tiger Brokers

BUZZ-Metsera plunges as bidding war ends with Pfizer securing $10 billion deal

Reuters
Nov 10, 2025
BUZZ-Metsera plunges as bidding war ends with Pfizer securing $10 billion deal

** Metsera MTSR.O shares plunge 15.7% to $70.12 premarket after a fierce bidding war for the drugmaker ended late on Friday

** MTSR accepts Pfizer's PFE.N $10 bln acquisition bid, and co-bidder Novo Nordisk NOVOb.CO said it would exit the race

** PFE agrees to pay $86.25/share in cash, a 3.69% upside to Metsera's Friday close

** Metsera accepted Pfizer's sweetened offer citing "unacceptably high legal and regulatory risks" in Novo's bid

** Bernstein says Pfizer's $10 billion valuation is optimistic, requiring $11 billion in revenue by 2040

** MTSR shares had surged nearly 60% last week amid bidding war

** MTSR shares have climbed more than threefold since their January IPO, while PFE stock is down 7.82% YTD, as of last close

(Reporting by Tharuniyaa Lakshmi and Pranav Kashyap in Bengaluru)

((tharuniyaa@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10